Help Us Protect Access to Sexual and Reproductive Health Care Today!
A new “one size fits most” diaphragm, Caya, was approved by the FDA in September 2014 and is now available in the US. Find out about the new diaphragm in this Contraceptive Pearl.
All patients deserve to be treated with the highest level of respect. When a patient is a member of the LGBT community, health care providers should take care to use the correct language so that the patient feels most comfortable.
Nearly 60% of women aged 15-44 in the United States have used withdrawal for birth control at least once. This contraceptive Pearl covers the pros and cons of this contraceptive method.
After an abortion, women may start ovulating very soon. This is why it is so important to be prompt with contraception. This Contraceptive Pearl focuses on use of the vaginal ring after an abortion.
Liletta, a new progestin intrauterine device (IUD), was approved by the FDA in February 2015. It is the same size and shape as the Mirena and contains the same dose of levonorgestrel. Learn more about Liletta by reading this edition of the Contraceptive Pearls.
Due to the risk of fetal anomalies with these medications, contraceptive counseling is particularly important for women taking anticonvulsants. This Contraceptive Pearl covers contraception and contraindications for patients on anticonvulsants.
For patients with a history of sexual trauma, pelvic exams may trigger PTSD symptoms. The techniques outlined in this Contraceptive Pearl of trauma-informed care can lead to an easier exam.
Some women avoid hormonal contraception due to concern about side effects. Other women want to steer clear of all medications. Regardless of their reason, women who prefer to avoid hormones have a variety of contraceptive options available.
The intrauterine device (IUD) is an excellent postpartum contraceptive method. Right after childbirth, women are certain that they are not pregnant, they are highly motivated to use contraception and they appreciate avoiding extra visits to the pharmacy or clinician’s office. This Contraceptive Pearl covers postpartum IUD insertion.
The LNG-IUD 13.5mg Progestin IUD, also known by its brand name, Skyla®, is the newest IUD approved by the FDA. This Contraceptive Pearl answers questions about the pros and cons of this contraceptive method.
Your gift allows us to mobilize, train, and support clinicians across the country to provide reproductive health care.